Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Cell-Based Therapy
  • Published:

Cell-Based Therapy

Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells

Abstract

Dendritic cells (DC) play a key role in antigen presentation and activation of specific immunity. Much current research focuses on harnessing the potency of DC for vaccines, gene therapy, and cancer immunotherapy applications. However, DC are not readily transfected in vitro by traditional nonviral techniques. A novel DNA vaccine formulation was used to determine if DC are transfected in vitro. The formulation consists of plasmid DNA adsorbed on to cationic microparticles composed of the biodegradable polymer polylactide-co-glycolide (PLG) and the cationic surfactant, cetyltrimethylammonium bromide (CTAB). Using preparations of fluorescent-labeled plasmid DNA formulated on PLG-CTAB microparticles to study internalization by macrophages and dendritic cells in vitro and in vivo, we found that most, but not all, of the fluorescence was concentrated in endosomal compartments. Furthermore, uptake of plasmid DNA encoding HIV p55 gag adsorbed to PLG-CTAB microparticles by murine bone marrow-derived dendritic cells resulted in target gene expression, as detected by RT-PCR. The antigen was subsequently processed and presented, resulting in stimulation of an H-2kd-restricted, gag-specific T cell hybridoma. Activation of the hybridoma, detected by IL-2 production, was dose-dependent in the range of 0.1–20 μg DNA (10–2000 μg PLG) and was sustained up to 5 days after transfection. Thus, adsorption of plasmid DNA on PLG-CTAB microparticles provides a potentially useful nonviral approach for in vitro transfection of dendritic cells.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Steinman R . The dendritic cells system and its role in immunogenicity Annu Rev Immunol 1991 9: 271–296

    Article  CAS  Google Scholar 

  2. Banchereau J, Steinman R . Dendritic cells and the control of immunity Nature 1998 392: 245–252

    Article  CAS  Google Scholar 

  3. Romani N, Gruner S, Brang D . Proliferating dendritic cell progenitors in human blood J Exp Med 1994 180: 83–93

    Article  CAS  Google Scholar 

  4. Thurner B et al. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application J Immunol Methods 1999 223: 1–15

    Article  CAS  Google Scholar 

  5. Inaba K et al. Identification of proliferating dendritic cell precursors in mouse blood J Exp Med 1992 175: 1157–1167

    Article  CAS  Google Scholar 

  6. Inaba K et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor J Exp Med 1992 176: 1693–1702

    Article  CAS  Google Scholar 

  7. Timmerman J, Levy R . Dendritic cell vaccines for cancer immunotherapy Ann Rev Med 1999 50: 507–529

    Article  CAS  Google Scholar 

  8. Mayordomo J, Zorina T, Storkus W . Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity Nature Med 1995 1: 1297–1302

    Article  CAS  Google Scholar 

  9. Fields R, Shimuzu K, Mule J . Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo Proc Natl Acad Sci USA 1998 95: 9482–9487

    Article  CAS  Google Scholar 

  10. Specht J, Wang G, Do M . Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases J Exp Med 1997 186: 1213–1221

    Article  CAS  Google Scholar 

  11. Song W, Kong H, Carpenter H . Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity J Exp Med 1997 186: 1247–1256

    Article  CAS  Google Scholar 

  12. Paglia P et al. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma Blood 1998 92: 3172–3176

    CAS  Google Scholar 

  13. Melero I et al. Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas Gene Therapy 1999 6: 1779–1784

    Article  CAS  Google Scholar 

  14. Wickham T . Targeting adenovirus Gene Therapy 2000 7: 110–114

    Article  CAS  Google Scholar 

  15. Sundaresan P, Hunter WD, Martuza RL, Rabkin SD . Attenuated, replication-competent herpes simplex virus type I mutant G207: safety evaluation in mice J Virol 2000 74: 3832–3841

    Article  CAS  Google Scholar 

  16. Fink D et al. Design and application of HSV vectors for neuroprotection Gene Therapy 2000 7: 115–119

    Article  CAS  Google Scholar 

  17. Arthur J et al. A comparison of gene transfer methods in human dendritic cells Cancer Gene Ther 1997 4: 17–25

    CAS  PubMed  Google Scholar 

  18. van Tendeloo V et al. Nonviral transfection of distinct types of human dendritic cells: high efficiency gene transfer by electroporation into hematopoietic progenitor, but not monocyte-derived dendritic cells Gene Therapy 1998 5: 700–707

    Article  CAS  Google Scholar 

  19. Luo D, Saltzman M . Synthetic DNA delivery systems Nat Biotechnol 2000 18: 33–37

    Article  CAS  Google Scholar 

  20. Lanzavecchia A . Mechanisms of antigen uptake for presentation Curr Opin Immunol 1996 8: 348–354

    Article  CAS  Google Scholar 

  21. Tabata I, Ikada Y . Phagocytosis of polymer microspheres by macrophages Adv Polymer Sci 1990 94: 107–141

    Article  CAS  Google Scholar 

  22. Singh M et al. Cationic microparticles: a potent delivery system for DNA vaccines Proc Natl Acad Sci USA 2000 97: 811–816

    Article  CAS  Google Scholar 

  23. Chavany C et al. Adsorption of oligonucleotides on to polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake Pharm Res 1994 11: 1370–1378

    Article  CAS  Google Scholar 

  24. Fattal E et al. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides J Control Release 1998 53: 137–143

    Article  CAS  Google Scholar 

  25. zur Megede J et al. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene J Virol 2000 74: 2628–2635

    Article  CAS  Google Scholar 

  26. Fields R et al. Comparative analysis of murine dendritic cells derived from spleen and bone marrow J Immunother 1998 21: 323–339

    Article  CAS  Google Scholar 

  27. Sanderson S, Shastri N . LacZ inducible, antigen/MHC-specific T cell hybrids Int Immunol 1994 6: 369–376

    Article  CAS  Google Scholar 

  28. Hedley M, Curley J, Urban R . Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses Nature Med 1998 4: 365–368

    Article  CAS  Google Scholar 

  29. Dupuis M et al. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice J Immunol 2000 165: 2850–2858

    Article  CAS  Google Scholar 

  30. Newman K et al. Cytoplasmic delivery of a fluorescent probe by poly(D,L lacticıcoıglycolic acid) microspheres AAPS Annual Meeting Abstracts Online 1999

    Google Scholar 

  31. Ciftci K, Su J . DNA-PLGA microparticles: a promising delivery system for cancer gene therapy AAPS Annual Meeting Abstracts Online 1999

    Google Scholar 

  32. Akbari O et al. DNA vaccination: transfection and activation of dendritic cells as key events for immunity J Exp Med 1999 189: 169–177

    Article  CAS  Google Scholar 

  33. Raychaudhuri S, Rock K . Fully mobilizing host defense: building better vaccines Nat Biotechnol 1998 16: 1025–1031

    Article  CAS  Google Scholar 

  34. Singh M, O'Hagan D . Advances in vaccine adjuvants Nat Biotechnol 1999 17: 1075–1081

    Article  CAS  Google Scholar 

  35. Zelphati O et al. Gene chemistry: functionally and conformationally intact fluorescent plasmid DNA Hum Gene Ther 1999 10: 15–24

    Article  CAS  Google Scholar 

  36. Doe B, Walker C . HIV-1 p24 Gag-specific cytotoxic T-lymphocyte responses in mice AIDS 1996 10: 793–806

    Article  CAS  Google Scholar 

  37. Paliard X, Doe B, Walker C . The T cell repertoire primed by antiviral vaccination is induced by self-tolerance Cell Immunol 1998 188: 73–79

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Special thanks to N Shastri, University of California Berkeley, for providing the fusion partner, BWZ.36, and Carolyn Woo who provided technical assistance in this study. Thanks to Marty Giedlin and Gillis Otten for helpful discussions. Funding for this project was supported by University of California BioSTAR Project S97-25 and NIH grant HL24136 from the National Heart Lung and Blood Institute.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Denis-Mize, K., Dupuis, M., MacKichan, M. et al. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Ther 7, 2105–2112 (2000). https://doi.org/10.1038/sj.gt.3301347

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301347

Keywords

This article is cited by

Search

Quick links